CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Taking Cell Isolation and Spray Technology to Next Level

Life Sciences Review | Wednesday, October 27, 2021
Tweet

The innovative product’s growing patent portfolio opens up new commercial options in fields such as cell treatments, biologics, drug delivery, and other sectors, allowing for smart business partnerships with potential partners.


FREMONT, CA:Today, developing and commercializing next-generation biomedical technology and devices to solve unmet medical needs is the need of the hour. To take their progressions a step ahead, RenovaCare, a developer of patented cell therapy technologies for the regeneration of skin and tissues, has designed a SkinGun. The RenovaCare SkinGun is a non-invasive mild cell spray that aids in the healing of burn wounds. The product was also recently awarded a patent by the United States Patent and Trademark Office.


The latest RenovaCare patent underscores the company’s dedication to new product development and the expansion of its patented cell isolation and spray technology platforms to cover biologics and drug delivery. Further, SkinGun’s growing patent portfolio opens up new commercial options in fields such as cell treatments, biologics, drug delivery, and other sectors, allowing for smart business partnerships with potential partners.


RenovaCare has had several technological advancements recently and growth of its intellectual property portfolio, with new patents awarded in the United States, Australia, Canada, and many European and Asian countries. “RenovaCare has adopted a global IP strategy focused on investing in technology and broadening our commercial opportunities domestically and abroad,” stated Dr. Kaiyo Nedd, CEO and President, RenovaCare. “A stronger patent portfolio better secures our technology from third-party appropriation and infringement while enhancing the value of our corporate assets.”


In May 2021, the FDA granted RenovaCare full Investigational Device Exemption, allowing the company to begin a clinical trial to assess the safety and feasibility of its SkinGun and CellMist Systems. The RenovaCare SkinGun and CellMist Systems are used in the CELLMIST 1 clinical trial to topically give autologous skin cells to deep second-degree thermal burn wounds in adults to aid recovery.


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/taking-cell-isolation-and-spray-technology-to-next-level-nwid-617.html